For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
News Release
Senate Vote a Setback for Public Health
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />Washington, D.C., July 24, 2003—The U.S. Senate yesterday approved a measure that would allow the Food…
Op-Eds
West Nile Virus: A Public Health Crisis?
Full article available in pdf format Public health officials can only hope that this summer doesn't see a repeat of last year's…
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…
News Release
Pharmaceutical Re-Imports Threaten Medical Innovation
Contact for Interviews: Richard Morrison, 202.331.2273 Washington, D.C., July 18, 2003—The Competitive Enterprise Institute is opposing proposals to allow the re-importation of drugs from foreign…
Op-Eds
Rules May Save Fuel but Won’t Save Lives
When it comes to saving fuel, federal Corporate Average Fuel Economy (CAFE) regulations are expensive, cumbersome and insidiously deadly. They force new technologies…